The immune response to respiratory syncytial virus infection: Friend or foe?

Clinical Reviews in Allergy and Immunology

Volumn 34, Issue 2, 2008, Pages 163-173

  Welliver Sr , Robert C ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Asthma; Bronchiolitis; Immune response; Infants; Respiratory syncytial virus infection

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CX3C CHEMOKINE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VIRUS VACCINE; AUTACOID; CYTOKINE; SURFACTANT ASSOCIATED PROTEIN; TOLL LIKE RECEPTOR; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; BASOPHIL; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; BIOSYNTHESIS; IMMUNOLOGY; INFANT; METABOLISM; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; VIROLOGY;

ANTIBODIES, VIRAL; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INFANT; INFLAMMATION MEDIATORS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 48649102936     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8033-2     Document Type: Review

References (101)

1. AJ Pelletier JM Mansbach CA Jr Camargo 2006 Direct medical costs of bronchiolitis hospitalizations in the United States Pediatrics 118 2418 2423
2. DK Shay RC Holman RD Newman LL Liu JW Stout LJ Anderson 1999 Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996 JAMA 282 1440 1446
3. JM Langely JC LeBlanc B Smith EE Wang 2003 Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000 J Infect Dis 188 1764 1767
4. RT Stein D Sherrill WJ Morgan CJ Holberg M Halonen LM Taussig AL Wright FD Martinez 1999 Respiratory syncytial virus in early life and risk of wheeze and allergy by 13 years Lancet 353 541 545
5. ML Everard 2006 The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children Curr Opin Allergy Clin Immunol 6 56 61
6. LJ Akinbami KC Schoendorf 2002 Trends in childhood asthma: prevalence, health care utilization, and mortality Pediatrics 110 315 322
7. WP Glezen LH Taber AL Frank JA Kasel 1986 Risk of primary infection and reinfection with respiratory syncytial virus Am J Dis Child 140 543 546
8. SF Dowell LJ Anderson HE Gary Jr DD Erdman JF Plouffe TM File Jr BJ Marston RF Breiman 1996 Respiratory syncytial virus is an important cause of community-acquired low respiratory infection among hospitalized adults J Infect Dis 174 456 462
9. EE Walsh DR Peterson AR Falsey 2004 Risk factors for severe respiratory syncytial virus infection in elderly persons J Infect Dis 189 233 238
10. E Whimbey RB Couch JA Englund M Andreeff JM Goodrich II Raad V Lewis N Mirza MA Luna B Baxter JJ Tarrand GP Bodey 1995 Respiratory syncytial virus pneumonia in hospitalized adult patient with leukemia Clin Infect Dis 21 376 379
11. JA Englund CJ Sullivan MC Jordan LP Dehner GM Vercellotti HH Balfour Jr 1988 Community respiratory virus infections among hospitalized adult bone marrow transplant recipients Ann Intern Med 109 203 208
12. MEB Wohl V Chernick 1978 Bronchiolitis Am Rev Respir Dis 118 759 781
13. HW Kim JG Canchola CD Brandt G Pyles RM Chanock K Jensen RH Parrott 1969 Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine Am J Epidemiol 89 422 434
14. AM Levine JA Whitsett 2001 Pulmonary collectins in innate host defense of the lung Microbes Infect 3 161 166
15. AM Levine J Gwozdz J Stark M Brune J Whitsett T Korfhagen 1999 Surfactant protein A enhances respiratory syncytial virus clearance in vivo J Clin Invest 103 1015 1021
16. R Ghildyal C Hartley A Varrasso J Meanger DR Voeker EM Anders J Mills 1999 Surfactant protein A binds to effusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity J Infect Dis 180 2009 2013
17. TP Hickling R Malhotra H Bright W McDowell ED Blair RB Sim 2000 Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells Viral Immunol 13 125 135
18. TP Hickling H Bright K Wing D Gower SL Martin RB Sim R Malhotra 1999 A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo Eur J Immunol 29 3478 3484
19. M Griese 2002 Respiratory syncytial virus and pulmonary surfactant Viral Immunol 15 357 363
20. M Lahti J Lofgren R Marttila M Renko T Klaavuniemi 2002 Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection Pediatr Res 51 696 699
21. J Lofgren M Ramet M Renko R Marttila M Hallman 2002 Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants J Infect Dis 185 283 289
22. K Takeda T Kaisho S Akira 2003 Toll-like receptors Annu Rev Immunol 21 335 376
23. BD Rudd E Burstein CS Duckett X Li NW Lukacs 2005 Differential role for TLR-3 in respiratory syncytial virus-induced chemokine expression J Virol 79 3350 3357
24. EA Kurt-Jones L Popva L Kwinn LM Haynes LP Jones 2000 Pattern recognition receptors TLR-4 and CD14 mediate response to respiratory syncytial virus Nat Immunol 1 398 401
25. MM Monick TO Yarovinsky LS Power NS Butler 2003 Respiratory syncytial virus upregulates TLR-4 and sensitizes airway epithelial cells to endotoxin J Biol Chem 278 53035 53044
26. M Baggiolini B Dewald B Moser 1997 Human chemokines: an update Annu Rev Immunol 15 675 705
27. Y Zhang BA Luxon A Casola RP Garofalo M Jamalludin AR Brasier 2001 Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays J Virol 75 9044 9058
28. B Olszewska-Pazdrak A Casola T Saito R Alam SE Crowe 1998 Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus J Virol 72 4756 4764
29. TL Noah S Becker 1993 Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line Am J Physiol 265 L472 L478
30. S Becker J Quay J Soukup 1991 Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages J Immunol 147 4307 4312
31. JM Soukup S Becker 2003 Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro Clin Immunol 107 178 185
32. P Sheeran H Jafri C Carubelli 1999 Elevated cytokine concentrations in the nasal pharyngeal and tracheal secretions of children with respiratory syncytial virus disease Pediatr Infect Dis J 18 115 122
33. RJ Garofalo J Patti KA Hintz V Hill PL Ogra RC Welliver 2001 Macrophage inflammatory protein 1α (not T-helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis J Infect Dis 184 393 399
34. HA Haeberle WA Kuziel A Dieterich A Casola 2001 Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1α in lung pathology J Virol 75 878 890
35. RC Welliver RP Garofalo PL Ogra 2002 Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection Pediatr Infect Dis J 21 457 461
36. J Hull K Rowlands E Lockhart C Moore M Sharland D Kwiatkowski 2003 Variance of a chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus J Infect Dis 188 904 907
37. MA Fiedler K Wernk-Dollries JM Stark 1995 Respiratory syncytial virus increases IL-8 gene expression in protein release in A549 cells Am J Physiol 269 L865 L872
38. H Tsutsumi R Takeuchi M Ohsaki K Seki S Chiba 1999 Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression J Leukoc Biol 66 99 104
39. JA Elias Z Zhu G Chupp RJ Homer 1999 Airway remodeling in asthma J Clin Invest 104 1001 1006
40. V Bitko A Velazquez L Yang YC Yang S Barik 1997 Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of MF-kappa B and is inhibited by sodium salicylate and aspirin Virology 232 369 378
41. LH Thomas JS Friendland M Sharland S Becker 1998 Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus mediated expression of inhibitor of kappa B alpha J Immunol 161 1007 1016
42. JG Mastronarde MM Monick N Mukaida K Matsuhima GW Hunninghake 1998 Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappa B in respiratory syncytial virus-infected interleukin 8 gene expression in airway epithelium J Infect Dis 177 1275 1281
43. BA Chini MA Fiedler L Milligan T Hopkins JM Stark 1998 Essential roles of NF-kappa B and C/EBP in the regulation of intercellular adhesion molecule-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures J Virol 72 1623 1626
44. HA Haeberle R Takizawa A Casola AR Brasier 2002 Respiratory syncytial virus-induced activation of nuclear factor-kappa B in the lung involves alveolar macrophages and Toll-like receptor 4-dependent pathways J Infect Dis 186 1199 1206
45. TL Noah FW Henderson IA Wortman 1995 Nasal cytokine production in viral acute respiratory infection of childhood J Infect Dis 171 584 592
46. TR Johnson S Hong L Van Kaer Y Koezuka BS Graham 2002 10K T cells contribute to the expansion of CD8 (positive) T cells and amplification of antiviral immune responses to respiratory syncytial virus J Virol 76 4294 4303
47. JA Hull A Thomson D Kwiatkowski 2000 Association of respiratory syncytial virus bronchiolitis with the interleukin-8 gene region in UK families Thorax 55 1023 1027
48. RL Smyth KJ Mobbs U O'Hea D Ashby CA Hart 2002 Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype Pediatr Pulmonol 33 339 346
49. R Merolla NA Rebert PT Tsiviste SP Hoffmann R Panuska 1995 Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta Am J Respir Crit Care Med 152 1358 1366
50. BE Chipps WF Sullivan JM Portnory 1993 Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus Pediatr Infect Dis 12 653 658
51. T Welliver RP Garofalo KH Hintz L Avendano K Sanchez H Jafri S Chavez-Bueno PL Ogra L McKinney J Reed RC Welliver Sr 2007 Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses J Infect Dis 195 1126 1136
52. SM van Schaik N Obut G Enhorning K Hintz K Gross GE Hancock AM Stack RC Welliver 2000 Level of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice J Med Virol 62 257 266
53. ML Everard A Swarbrick M Wrightham J McIntyre C Dunkley PD James HF Sewell AD Milner 1994 Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection Arch Dis Child 71 428 432
54. S-Z Wang H Xu A Wraith JJ Bowden 1998 Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus Eur Respir J 12 612 618
55. S Wang KD Forsyth 2000 The interaction of neutrophils with respiratory epithelial cells in viral infection Respirology 5 1 9
56. S Becker J Quay J Soukup 1991 Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophage J Immunol 147 4307 4312
57. S Krishnan M Craven RC Welliver N Ahmad M Halonen 2003 Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates J Infect Dis 188 433 439
58. FE Barr H Pedigo TR Johnson VL Shepherd 2000 Surfactant protein-A enhances uptake of respiratory syncytial virus by mononcytes and U937 macrophages Am J Respir Cell Mol Biol 23 586 592
59. KM Neuzil Y Tang BS Graham 1996 Protective role of TNF-α in respiratory syncytial virus infection in vitro and in vivo Am J Med Sci 311 201 204
60. T Hussell A Pennycook PJ Openshaw 2001 Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology Eur J Immunol 31 2566 2573
61. R Garofalo JL Kimpen RC Welliver PL Ogra 1992 Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection J Pediatr 120 28 32
62. C Zelaya EA Orvell O Strannegard 1994 Eosinophil cationic protein in nasopharyngeal secretions in serum of infants infected with respiratory syncytial virus Pediatr Allergy Immunol 5 100 106
63. JB Domachowske KD Dyer CA Bonville HF Rosenberg 1998 Recombinant human eosinophil-derived neurotoxin/RNase2 functions as an effective antiviral agent against respiratory syncytial virus J Infect Dis 177 1458 1464
64. JB Domachowske KD Dyer AG Adams TL Leto HF Rosenberg 1998 Eosinophil cationic protein/RNase3 is another RNase A-family ribonuclease with direct antiviral activity Nucleic Acids Res 26 3358 3363
65. AM Bramley TZ Vitalis BR Wiggs RG Hegele 1999 Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea pigs Eur Respir J 14 1061 1067
66. K Wedde-Beer C Hu MM Rodriguez G Piedimonte 2002 Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus Am J Physiol Lung Cell Mol Physiol 282 L1143 L1150
67. RC Welliver DT Wong M Sun E Middleton Jr RS Vaughan PL Ogra 1981 The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection N Engl J Med 305 841 846
68. B Volovitz RC Welliver G DeCastro D Krystofik PL Ogra 1988 The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease Pediatr Res 24 504 507
69. ML Everard G Fox AF Walls D Quint 1995 Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis Arch Dis Child 72 64 69
70. BN Lambrecht I Carro-Muino K Vermaelen RA Pauwels 1999 Allergen induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats Am J Respir Cell Mol Biol 20 1165 1174
71. BN Lambrecht RA Peleman GR Bullock RA Pauwels 2000 Sensitization to inhaled antigen by intratracheal instillation of dendritic cells Clin Exp Allergy 30 214 220
72. JC Huh DH Strickland FL Jahnsen DJ Turner 2003 Bidirectional interactions between antigen-bearing respiratory tract dendritic cells and T cell precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma J Exp Med 198 19 30
73. PG Holt PA Stumbles 2000 Characterization of dendritic cell populations in the respiratory tract J Aerosol Med 13 361 367
74. WL Trepicchio L Wang M Bozza AJ Dorner 1997 IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappa B B J Immunol 159 5661 5670
75. MA Gill AK Palucka T Barton F Ghaffer H Jafri J Banchereau O Ramilo 2005 Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections J Infect Dis 191 1105 1115
76. CA Biron KB Nguyen GC Pien LP Cousens TP Salazar-Mather 1999 Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 189 220
77. JJ Anderson M Serin J Harrop S Amin 1989 Natural killer cell response to respiratory syncytial virus in the BALB/c mouse model Adv Exp Med Biol 257 211 220
78. T Hussell PJ Openshaw 1998 Intracellular IFN-γ expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection J Gen Virol 79 2593 2601
79. T Hussell PJ Openshaw 2000 IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions J Immunol 165 7109 7115
80. JH Aberle SW Aberle MN Dworzak CW Mandl 1999 Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease Am J Respir Crit Care Med 160 1263 1268
81. L Bont CJ Heijnen A Kavelaars WM van Aalderen 2001 Local interferon-γ levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity J Infect Dis 184 355 358
82. RC Welliver TN Kaul TI Putnam M Sun K Riddlesberger PL Ogra 1980 The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class specific responses J Pediatr 96 808 813
83. K McIntosh HB Masters I Orr RK Chao RM Barkin 1978 The immunologic response to infection with respiratory syncytial virus in infants J Infect Dis 138 24 32
84. TN Kaul RC Welliver DT Wong RA Udwadia K Riddlesberger PL Ogra 1981 Secretory antibody response to respiratory syncytial virus infection Am J Dis Child 135 1013 1016
85. WP Glezen A Paredes JE Allison L Taber AL Frank 1981 Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level J Pediatr 98 708 715
86. CB Hall EE Walsh CE Long KC Schnabel 1991 Immunity to and frequency of reinfection with respiratory syncytial virus J Infect Dis 163 693 698
87. The IMpact-RSV Study Group 1998 Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 531 537
88. RHD Bui GA Molinaro JD Kettering DC Heiner DT Imagawa JW St. Geme Jr 1987 Virus specific IgE and IgG for antibodies in serum of children infected with respiratory syncytial virus J Pediatr 110 87 90
89. S Rabatic A Gagro R Lokar-Kolbas V Krsulovic-Hresic Z Vrtar T Popow-Kraupp V Drazenovic G Mlinaric-Galinovic 1997 Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG for antibodies specific for respiratory syncytial virus J Infect Dis 175 32 37
90. JC Russi A Delfraro MD Borthagaray B Velazquez B Garcia-Barreno M Hortal 1993 Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions in children with respiratory syncytial virus infections J Clin Microbiol 31 819 823
91. RC Welliver TN Kaul PL Ogra 1980 The appearance of cell-bound IgE in respiratory tract epithelium after respiratory syncytial virus infection N Engl J Med 303 1198 1202
92. CRM Bangham AJ McMichael 1986 Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus Proc Natl Acad Sci U S A 83 9183 9187
93. Y Chiba Y Higashidate K Suga K Honjo H Tsutsumi PL Ogra 1989 Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection J Med Virol 28 133 139
94. IN Mbawuike J Wells R Byrd SG Cron WP Glezen PA Piedra 2001 HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-γ, and interleukin-4 responses to respiratory syncytial virus infection in infants and children J Infect Dis 183 687 696
95. D Isaacs CRM Bangham AJ McMichael 1987 Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis Lancet 2 769 771
96. JP Legg IR Hussain JA Warner SL Johnston JO Warner 2003 Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis Am J Respir Crit Care Med 168 633 639
97. AH Cherrie K Anderson GW Wertz PJM Openshaw 1992 Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1B proteins of respiratory syncytial virus J Virol 66 2102 2110
98. SM van Schaik DA tristram IS Nagpal KM Hintz RC Welliver II RC Welliver 1999 Increased production of interferon-γ and cysteinyl leukotrienes in virus-induced wheezing J Allergy Clin Immunol 103 630 636
99. ML Everard G Fox AF Walls D Quint R Fifield C Walters A Swarbrick AD Milner 1995 Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis Arch Dis Child 72 64 69
100. Y Sznajer JY Westcott SE Wenzel B Mazer M Tucci BJ Toledano 2004 Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis J Pediatr 145 115 118
101. RC Welliver KH Hintz M Glori RC Welliver Sr 2003 Zilutin reduces respiratory illness and lung inflammation during respiratory syncytial virus infection in mice J Infect Dis 187 1773 1779